世界の抗うつ薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antidepressants Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3826 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、抗うつ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（三環系抗うつ薬、セロトニン-ノルエピネフリン阻害薬、非定型抗精神病薬、選択的セロトニン再取り込み阻害薬、ベンゾジアゼピン、四環系抗うつ薬、モノアミン酸化酵素阻害薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗うつ薬の市場動向 ・企業の競争状況、市場シェア ・抗うつ薬の種類別市場規模と予測2016-2027（三環系抗うつ薬、セロトニン-ノルエピネフリン阻害薬、非定型抗精神病薬、選択的セロトニン再取り込み阻害薬、ベンゾジアゼピン、四環系抗うつ薬、モノアミン酸化酵素阻害薬、その他） ・抗うつ薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・抗うつ薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗うつ薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗うつ薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗うつ薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗うつ薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AstraZeneca、Eli Lilly and Company、Novartis、GlaxoSmithKline、Otsuka Pharmaceutical、Abbott Laboratories、Gedeon Richter、Janssen Pharmaceuticals、Lupin Pharmaceuticals、Luye Pharma、MSI Methylation Sciences、Naurex、SK Biopharmaceuticals） ・結論

Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions.

Market Analysis and Insights: Global Antidepressants Drugs Market
The global Antidepressants Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antidepressants Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antidepressants Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antidepressants Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antidepressants Drugs market.

Global Antidepressants Drugs Scope and Market Size
Antidepressants Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antidepressants Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tricyclic Antidepressants
Serotonin-norepinephrine Inhibitors
Atypical Antipsychotics
Selective Serotonin Reuptake Inhibitors
Benzodiazepines
Tetracyclic Antidepressants
Monoamine Oxidase Inhibitors
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
AstraZeneca
Eli Lilly and Company
Novartis
GlaxoSmithKline
Otsuka Pharmaceutical
Abbott Laboratories
Gedeon Richter
Janssen Pharmaceuticals
Lupin Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Naurex
SK Biopharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antidepressants Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tricyclic Antidepressants
1.2.3 Serotonin-norepinephrine Inhibitors
1.2.4 Atypical Antipsychotics
1.2.5 Selective Serotonin Reuptake Inhibitors
1.2.6 Benzodiazepines
1.2.7 Tetracyclic Antidepressants
1.2.8 Monoamine Oxidase Inhibitors
1.2.9 Others
1.3 Market by Application
1.3.1 Global Antidepressants Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antidepressants Drugs Market Perspective (2016-2027)
2.2 Antidepressants Drugs Growth Trends by Regions
2.2.1 Antidepressants Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antidepressants Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Antidepressants Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Antidepressants Drugs Industry Dynamic
2.3.1 Antidepressants Drugs Market Trends
2.3.2 Antidepressants Drugs Market Drivers
2.3.3 Antidepressants Drugs Market Challenges
2.3.4 Antidepressants Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antidepressants Drugs Players by Revenue
3.1.1 Global Top Antidepressants Drugs Players by Revenue (2016-2021)
3.1.2 Global Antidepressants Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Antidepressants Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antidepressants Drugs Revenue
3.4 Global Antidepressants Drugs Market Concentration Ratio
3.4.1 Global Antidepressants Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antidepressants Drugs Revenue in 2020
3.5 Antidepressants Drugs Key Players Head office and Area Served
3.6 Key Players Antidepressants Drugs Product Solution and Service
3.7 Date of Enter into Antidepressants Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antidepressants Drugs Breakdown Data by Type
4.1 Global Antidepressants Drugs Historic Market Size by Type (2016-2021)
4.2 Global Antidepressants Drugs Forecasted Market Size by Type (2022-2027)

5 Antidepressants Drugs Breakdown Data by Application
5.1 Global Antidepressants Drugs Historic Market Size by Application (2016-2021)
5.2 Global Antidepressants Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antidepressants Drugs Market Size (2016-2027)
6.2 North America Antidepressants Drugs Market Size by Type
6.2.1 North America Antidepressants Drugs Market Size by Type (2016-2021)
6.2.2 North America Antidepressants Drugs Market Size by Type (2022-2027)
6.2.3 North America Antidepressants Drugs Market Size by Type (2016-2027)
6.3 North America Antidepressants Drugs Market Size by Application
6.3.1 North America Antidepressants Drugs Market Size by Application (2016-2021)
6.3.2 North America Antidepressants Drugs Market Size by Application (2022-2027)
6.3.3 North America Antidepressants Drugs Market Size by Application (2016-2027)
6.4 North America Antidepressants Drugs Market Size by Country
6.4.1 North America Antidepressants Drugs Market Size by Country (2016-2021)
6.4.2 North America Antidepressants Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antidepressants Drugs Market Size (2016-2027)
7.2 Europe Antidepressants Drugs Market Size by Type
7.2.1 Europe Antidepressants Drugs Market Size by Type (2016-2021)
7.2.2 Europe Antidepressants Drugs Market Size by Type (2022-2027)
7.2.3 Europe Antidepressants Drugs Market Size by Type (2016-2027)
7.3 Europe Antidepressants Drugs Market Size by Application
7.3.1 Europe Antidepressants Drugs Market Size by Application (2016-2021)
7.3.2 Europe Antidepressants Drugs Market Size by Application (2022-2027)
7.3.3 Europe Antidepressants Drugs Market Size by Application (2016-2027)
7.4 Europe Antidepressants Drugs Market Size by Country
7.4.1 Europe Antidepressants Drugs Market Size by Country (2016-2021)
7.4.2 Europe Antidepressants Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antidepressants Drugs Market Size (2016-2027)
8.2 Asia-Pacific Antidepressants Drugs Market Size by Type
8.2.1 Asia-Pacific Antidepressants Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antidepressants Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antidepressants Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Antidepressants Drugs Market Size by Application
8.3.1 Asia-Pacific Antidepressants Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antidepressants Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antidepressants Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Antidepressants Drugs Market Size by Region
8.4.1 Asia-Pacific Antidepressants Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antidepressants Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antidepressants Drugs Market Size (2016-2027)
9.2 Latin America Antidepressants Drugs Market Size by Type
9.2.1 Latin America Antidepressants Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Antidepressants Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Antidepressants Drugs Market Size by Type (2016-2027)
9.3 Latin America Antidepressants Drugs Market Size by Application
9.3.1 Latin America Antidepressants Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Antidepressants Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Antidepressants Drugs Market Size by Application (2016-2027)
9.4 Latin America Antidepressants Drugs Market Size by Country
9.4.1 Latin America Antidepressants Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Antidepressants Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antidepressants Drugs Market Size (2016-2027)
10.2 Middle East & Africa Antidepressants Drugs Market Size by Type
10.2.1 Middle East & Africa Antidepressants Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antidepressants Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antidepressants Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Antidepressants Drugs Market Size by Application
10.3.1 Middle East & Africa Antidepressants Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antidepressants Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antidepressants Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Antidepressants Drugs Market Size by Country
10.4.1 Middle East & Africa Antidepressants Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antidepressants Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antidepressants Drugs Introduction
11.1.4 Pfizer Revenue in Antidepressants Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Antidepressants Drugs Introduction
11.2.4 AstraZeneca Revenue in Antidepressants Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Antidepressants Drugs Introduction
11.3.4 Eli Lilly and Company Revenue in Antidepressants Drugs Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Antidepressants Drugs Introduction
11.4.4 Novartis Revenue in Antidepressants Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antidepressants Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Antidepressants Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Details
11.6.2 Otsuka Pharmaceutical Business Overview
11.6.3 Otsuka Pharmaceutical Antidepressants Drugs Introduction
11.6.4 Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2016-2021)
11.6.5 Otsuka Pharmaceutical Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Antidepressants Drugs Introduction
11.7.4 Abbott Laboratories Revenue in Antidepressants Drugs Business (2016-2021)
11.7.5 Abbott Laboratories Recent Development
11.8 Gedeon Richter
11.8.1 Gedeon Richter Company Details
11.8.2 Gedeon Richter Business Overview
11.8.3 Gedeon Richter Antidepressants Drugs Introduction
11.8.4 Gedeon Richter Revenue in Antidepressants Drugs Business (2016-2021)
11.8.5 Gedeon Richter Recent Development
11.9 Janssen Pharmaceuticals
11.9.1 Janssen Pharmaceuticals Company Details
11.9.2 Janssen Pharmaceuticals Business Overview
11.9.3 Janssen Pharmaceuticals Antidepressants Drugs Introduction
11.9.4 Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2016-2021)
11.9.5 Janssen Pharmaceuticals Recent Development
11.10 Lupin Pharmaceuticals
11.10.1 Lupin Pharmaceuticals Company Details
11.10.2 Lupin Pharmaceuticals Business Overview
11.10.3 Lupin Pharmaceuticals Antidepressants Drugs Introduction
11.10.4 Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2016-2021)
11.10.5 Lupin Pharmaceuticals Recent Development
11.11 Luye Pharma
11.11.1 Luye Pharma Company Details
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Antidepressants Drugs Introduction
11.11.4 Luye Pharma Revenue in Antidepressants Drugs Business (2016-2021)
11.11.5 Luye Pharma Recent Development
11.12 MSI Methylation Sciences
11.12.1 MSI Methylation Sciences Company Details
11.12.2 MSI Methylation Sciences Business Overview
11.12.3 MSI Methylation Sciences Antidepressants Drugs Introduction
11.12.4 MSI Methylation Sciences Revenue in Antidepressants Drugs Business (2016-2021)
11.12.5 MSI Methylation Sciences Recent Development
11.13 Naurex
11.13.1 Naurex Company Details
11.13.2 Naurex Business Overview
11.13.3 Naurex Antidepressants Drugs Introduction
11.13.4 Naurex Revenue in Antidepressants Drugs Business (2016-2021)
11.13.5 Naurex Recent Development
11.14 SK Biopharmaceuticals
11.14.1 SK Biopharmaceuticals Company Details
11.14.2 SK Biopharmaceuticals Business Overview
11.14.3 SK Biopharmaceuticals Antidepressants Drugs Introduction
11.14.4 SK Biopharmaceuticals Revenue in Antidepressants Drugs Business (2016-2021)
11.14.5 SK Biopharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antidepressants Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tricyclic Antidepressants
Table 3. Key Players of Serotonin-norepinephrine Inhibitors
Table 4. Key Players of Atypical Antipsychotics
Table 5. Key Players of Selective Serotonin Reuptake Inhibitors
Table 6. Key Players of Benzodiazepines
Table 7. Key Players of Tetracyclic Antidepressants
Table 8. Key Players of Monoamine Oxidase Inhibitors
Table 9. Key Players of Others
Table 10. Global Antidepressants Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Antidepressants Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Antidepressants Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Antidepressants Drugs Market Share by Regions (2016-2021)
Table 14. Global Antidepressants Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Antidepressants Drugs Market Share by Regions (2022-2027)
Table 16. Antidepressants Drugs Market Trends
Table 17. Antidepressants Drugs Market Drivers
Table 18. Antidepressants Drugs Market Challenges
Table 19. Antidepressants Drugs Market Restraints
Table 20. Global Antidepressants Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Antidepressants Drugs Market Share by Players (2016-2021)
Table 22. Global Top Antidepressants Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidepressants Drugs as of 2020)
Table 23. Ranking of Global Top Antidepressants Drugs Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Antidepressants Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Antidepressants Drugs Product Solution and Service
Table 27. Date of Enter into Antidepressants Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Antidepressants Drugs Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Antidepressants Drugs Revenue Market Share by Type (2016-2021)
Table 31. Global Antidepressants Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Antidepressants Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Antidepressants Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Antidepressants Drugs Revenue Market Share by Application (2016-2021)
Table 35. Global Antidepressants Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Antidepressants Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Antidepressants Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Antidepressants Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Antidepressants Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Antidepressants Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Antidepressants Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Antidepressants Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Antidepressants Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Antidepressants Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Antidepressants Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Antidepressants Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Antidepressants Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Antidepressants Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Antidepressants Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Antidepressants Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Antidepressants Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Antidepressants Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Antidepressants Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Antidepressants Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Antidepressants Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Antidepressants Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Antidepressants Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Antidepressants Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Antidepressants Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Antidepressants Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Antidepressants Drugs Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Antidepressants Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Antidepressants Drugs Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Antidepressants Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Antidepressants Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Antidepressants Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Antidepressants Drugs Product
Table 70. Pfizer Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Antidepressants Drugs Product
Table 75. AstraZeneca Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Eli Lilly and Company Company Details
Table 78. Eli Lilly and Company Business Overview
Table 79. Eli Lilly and Company Antidepressants Drugs Product
Table 80. Eli Lilly and Company Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 81. Eli Lilly and Company Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Antidepressants Drugs Product
Table 85. Novartis Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Antidepressants Drugs Product
Table 90. GlaxoSmithKline Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Otsuka Pharmaceutical Company Details
Table 93. Otsuka Pharmaceutical Business Overview
Table 94. Otsuka Pharmaceutical Antidepressants Drugs Product
Table 95. Otsuka Pharmaceutical Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 96. Otsuka Pharmaceutical Recent Development
Table 97. Abbott Laboratories Company Details
Table 98. Abbott Laboratories Business Overview
Table 99. Abbott Laboratories Antidepressants Drugs Product
Table 100. Abbott Laboratories Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 101. Abbott Laboratories Recent Development
Table 102. Gedeon Richter Company Details
Table 103. Gedeon Richter Business Overview
Table 104. Gedeon Richter Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 105. Gedeon Richter Recent Development
Table 106. Janssen Pharmaceuticals Company Details
Table 107. Janssen Pharmaceuticals Business Overview
Table 108. Janssen Pharmaceuticals Antidepressants Drugs Product
Table 109. Janssen Pharmaceuticals Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 110. Janssen Pharmaceuticals Recent Development
Table 111. Lupin Pharmaceuticals Company Details
Table 112. Lupin Pharmaceuticals Business Overview
Table 113. Lupin Pharmaceuticals Antidepressants Drugs Product
Table 114. Lupin Pharmaceuticals Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 115. Lupin Pharmaceuticals Recent Development
Table 116. Luye Pharma Company Details
Table 117. Luye Pharma Business Overview
Table 118. Luye Pharma Antidepressants Drugs Product
Table 119. Luye Pharma Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 120. Luye Pharma Recent Development
Table 121. MSI Methylation Sciences Company Details
Table 122. MSI Methylation Sciences Business Overview
Table 123. MSI Methylation Sciences Antidepressants Drugs Product
Table 124. MSI Methylation Sciences Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 125. MSI Methylation Sciences Recent Development
Table 126. Naurex Company Details
Table 127. Naurex Business Overview
Table 128. Naurex Antidepressants Drugs Product
Table 129. Naurex Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 130. Naurex Recent Development
Table 131. SK Biopharmaceuticals Company Details
Table 132. SK Biopharmaceuticals Business Overview
Table 133. SK Biopharmaceuticals Antidepressants Drugs Product
Table 134. SK Biopharmaceuticals Revenue in Antidepressants Drugs Business (2016-2021) & (US$ Million)
Table 135. SK Biopharmaceuticals Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antidepressants Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tricyclic Antidepressants Features
Figure 3. Serotonin-norepinephrine Inhibitors Features
Figure 4. Atypical Antipsychotics Features
Figure 5. Selective Serotonin Reuptake Inhibitors Features
Figure 6. Benzodiazepines Features
Figure 7. Tetracyclic Antidepressants Features
Figure 8. Monoamine Oxidase Inhibitors Features
Figure 9. Others Features
Figure 10. Global Antidepressants Drugs Market Share by Application: 2020 VS 2027
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Antidepressants Drugs Report Years Considered
Figure 15. Global Antidepressants Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Antidepressants Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Antidepressants Drugs Market Share by Regions: 2020 VS 2027
Figure 18. Global Antidepressants Drugs Market Share by Regions (2022-2027)
Figure 19. Global Antidepressants Drugs Market Share by Players in 2020
Figure 20. Global Top Antidepressants Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidepressants Drugs as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Antidepressants Drugs Revenue in 2020
Figure 22. Global Antidepressants Drugs Revenue Market Share by Type (2016-2021)
Figure 23. Global Antidepressants Drugs Revenue Market Share by Type (2022-2027)
Figure 24. North America Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Antidepressants Drugs Market Share by Type (2016-2027)
Figure 26. North America Antidepressants Drugs Market Share by Application (2016-2027)
Figure 27. North America Antidepressants Drugs Market Share by Country (2016-2027)
Figure 28. United States Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Antidepressants Drugs Market Share by Type (2016-2027)
Figure 32. Europe Antidepressants Drugs Market Share by Application (2016-2027)
Figure 33. Europe Antidepressants Drugs Market Share by Country (2016-2027)
Figure 34. Germany Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Antidepressants Drugs Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Antidepressants Drugs Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Antidepressants Drugs Market Share by Region (2016-2027)
Figure 44. China Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Antidepressants Drugs Market Share by Type (2016-2027)
Figure 52. Latin America Antidepressants Drugs Market Share by Application (2016-2027)
Figure 53. Latin America Antidepressants Drugs Market Share by Country (2016-2027)
Figure 54. Mexico Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Antidepressants Drugs Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Antidepressants Drugs Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Antidepressants Drugs Market Share by Country (2016-2027)
Figure 60. Turkey Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Antidepressants Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pfizer Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 68. Otsuka Pharmaceutical Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 69. Abbott Laboratories Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 70. Gedeon Richter Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 71. Janssen Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 72. Lupin Pharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 73. Luye Pharma Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 74. MSI Methylation Sciences Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 75. Naurex Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 76. SK Biopharmaceuticals Revenue Growth Rate in Antidepressants Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---